CHANGE IN RATINGS

Biogen Idec

(BIIB) - Get Report

upgraded at Goldman Sachs to Buy from Neutral based on valuation and potential upside to earnings. Price target raised to $61 from $57.

Caterpillar

(CAT) - Get Report

upgraded at UBS to Neutral from Sell and price target reduced to $34 from $35. 2009 EPS estimate reduced to $2.50 from $3.50 and 2010 EPS estimate reduced to $2.25 from $3.00.

VMware

(VMW) - Get Report

downgraded at Merrill/BofA to Underperform from Neutral and price target reduced to $15 from $31.

STOCK COMMENTS / EPS CHANGES

American Express

(AXP) - Get Report

price target lowered at Goldman to $19 from $22. Maintained Neutral rating.

Caterpillar numbers cut at Morgan Stanley through 2010. Underweight rating and $28 price target.

Dreamworks

(DWA)

numbers cut at UBS through 2009. Sell rating and new $20 price target.

Eastman Chemical

(EMN) - Get Report

numbers cut at Barclays. Shares now seen reaching $29. Estimates also lowered, to reflect slower economic growth. Equal-weight rating.

Harley-Davidson

(HOG) - Get Report

price target trimmed at Goldman to $10 from $11. Removed stock from Conviction Sell list but maintained Sell rating.

Kimberly-Clark

(KMB) - Get Report

numbers lowered at UBS. Shares now seen reaching $63. Estimates also cut. Buy rating.

McDonald's

(MCD) - Get Report

numbers raised at Morgan Stanley. Shares now expected to reach $68. Estimates also boosted, despite the stronger dollar. Overweight rating.

Starbucks

(SBUX) - Get Report

numbers reduced at UBS. Shares now expected to reach $13. Estimates also lowered, to reflect continued same-store sales declines. Buy rating.

Sherwin-Williams

(SHW) - Get Report

numbers cut at Morgan Stanley. 2009 estimates cut because of weaker volumes and a higher pension expense. Overweight rating and new $56 price target.

Texas Instruments

(TXN) - Get Report

estimates cut at UBS through 2010. Neutral rating and $15 price target.

This article was written by a staff member of TheStreet.com.